Sugi Predict

Sugi Predict / Compounds / SCHEMBL504353

SCHEMBL504353

SCHEMBL504353

O=C(O)CCCCC[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.65
▸ MEN1 O00255 3/20 0.65
▸ KMT2A Q03164 3/20 0.65
▸ BLM P54132 1/20 0.65
▸ HBB P68871 1/20 0.65
▸ HIF1A Q16665 1/20 0.65
▸ TSHR P16473 5/20 0.57
▸ NFKB1 P19838 1/20 0.57
▸ PMP22 Q01453 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.50
▸ GPR84 Q9NQS5 7/20 0.48
▸ FFAR1 O14842 2/20 0.48
▸ FFAR4 Q5NUL3 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ PPARG P37231 6/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2371134 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL2370652 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL1119124 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL2371891 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL2372027 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL2371874 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL5828245 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL2380101 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL11701621 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB
SCHEMBL2371273 1.00 LMNA (0.65) LMNAMEN1KMT2ABLMHBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 — — EP claimed
CN-119191985-A Method for preparing 6-nitrohexanoic acid from aminocaproic acid and application thereof 上海荣迪生物技术有限公司 2024-12-27 — — CN claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 — — WO claimed
US-10072043-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2018-09-11 — — US claimed
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES Indiana University Research and Technology Corpora tion (US) 2016-06-23 — — US claimed
US-9217012-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-12-22 — — US claimed
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) 2012-04-12 — — US claimed
WO-2010118241-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2010-10-14 — — WO claimed
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 — — US claimed
CN-101654461-A Diphosphonic acid derivative containing NO donors, preparation method thereof and application thereof UNIV BEIJING NORMAL 2010-02-24 — — CN claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 — — US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 — — US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 — — US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 — — US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 — — US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 — — US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 — — US claimed
US-12551555-B2 Compositions and methods for potentiating immune activity KUMQUAT BIOSCIENCES INC. (US) 2026-02-17 — — US disclosed
US-4138586-A NITROALKANECARBOXYLIC ESTER WITH ALKALI HYDROXIDE, OZONIZING HOFFMANN-LA ROCHE INC. (US) 1979-02-06 — — US disclosed
US-4035400-A Preparation of omega-nitroalkanoic acids TEXACO INC. (US) 1977-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072043-B2 Inhibitors of protein tyrosine phosphatases PTPRCAP, PTPRF, PTPRS LMNA 4734/4885MEN1 4428/4885KMT2A 2681/4885
US-12551555-B2 Compositions and methods for potentiating immune activity PTPRCAP, PTPN2, PTPRC LMNA 4799/4885MEN1 4405/4885KMT2A 2377/4885
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS LMNA 4734/4885MEN1 4428/4885KMT2A 2681/4885
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 LMNA 1769/4885MEN1 685/4885KMT2A 1624/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 LMNA 2024/4885MEN1 1466/4885KMT2A 826/4885
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS LMNA 4734/4885MEN1 4428/4885KMT2A 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.